Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden
about
Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studiesManaging cardiovascular risk in patients with inflammatory arthritis: practical considerationsCardiac involvement in adult and juvenile idiopathic inflammatory myopathiesRisk of subarachnoid haemorrhage in people admitted to hospital with selected immune-mediated diseases: record-linkage studies.Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohortsCardiovascular involvement in autoimmune diseases.Inflammatory bowel disease and thromboembolismSteroid replacement in primary adrenal failure does not appear to affect circulating adipokines.Aspirin and multiple sclerosisRisk of Peripheral Arterial Occlusive Disease in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort StudyIncreased Risk of Intracerebral Hemorrhage Among Patients With Hepatitis C Virus Infection.Association Between Reduced Risk of Intracerebral Hemorrhage and Pelvic Inflammatory DiseaseAlterations to the middle cerebral artery of the hypertensive-arthritic rat model potentiates intracerebral hemorrhage.Serum homocysteine levels are decreased in levothyroxine-treated women with autoimmune thyroiditis.Damage assessment in ANCA-associated vasculitis.Rheumatoid arthritis and cardiovascular diseaseUpdates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes.Risk of ischemic stroke in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis.Risk of ischemic stroke in patients with systemic sclerosis: A systematic review and meta-analysis.Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.The evolving concept of SLE comorbidities.Association of hepatitis B virus infection with decreased ischemic stroke.Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study.Decreased risk of intracerebral hemorrhage among patients with milder allergic rhinitis.Increased risk of stroke among patients with Crohn's disease: a population-based matched cohort study.Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study.Autoimmune thyroid disease: a novel risk factor for atherosclerosis?Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study.Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden.The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?Population-based study suggests an increased risk of Alzheimer'sdisease in Sjögren's syndrome.Increased risk of coronary heart disease among patients with primary Sjögren's syndrome: a nationwide population-based cohort study.Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies.Etiologies des accidents vasculaires cérébraux ischémiques chez les jeunes: apport de l’internisteIncreased risk of stroke among patients with ulcerative colitis: a population-based matched cohort study
P2860
Q26771476-1E69A0B3-65B9-49A8-83F3-3DE5D4230309Q27694518-F5A296B6-B475-4DEB-A868-0F4EE0C2EC04Q28079786-11735E28-93AD-49D1-A027-F37F7348D26EQ33411448-3C420A4F-3732-4E3D-9CBE-31A56D718DD1Q33879759-CCD643C3-D05E-497C-84B1-8B74F633147DQ34081242-1682E036-A479-4408-B74E-085AA71A6AC7Q34326640-FF09A4E9-78C3-448B-BE55-52E50DD78F0BQ35153036-D72F80D7-8282-41F0-8C8C-53C10A32DFF7Q35678040-BBCDE8B6-C318-4854-BFE3-1456473AEFA0Q36299359-62951AFB-5F74-46B7-A11E-D4046CCC9F9AQ36299364-40F018D2-832A-4E2C-BA32-DC06D936DDB4Q36567022-4A38D6D9-4D83-419E-9AEA-AB65246A4DC1Q37402723-EF730949-C582-4546-9709-A0A984B39DE3Q37623995-557AEE28-AC2C-4EA4-AB69-432BF7C1B0FBQ38043946-67A4387F-8545-43B3-A70B-EFC75891D46BQ38149252-56A38F24-83A5-4505-8257-208416D3C316Q38249105-D91582F2-560E-4A97-8C91-5D35E0FEFB86Q38263671-0A409370-52E3-4110-96D4-2611EE9BC601Q38508194-C1873EA5-BDF2-46C0-B15F-1C5AB1F447EFQ38764974-20148444-764C-4669-AC96-B1B3BDB3757AQ38844621-9D6A080B-BF74-42F5-8DEF-7B78F9F86C9BQ39283399-442A11DE-9B73-4B19-9C2B-55FBEF7AB36BQ39328672-1FD9FCA1-56B0-432C-94E1-A2BF9FD4E00EQ40479785-E1847EDE-C079-43D1-AABC-899F3C31652DQ40888304-941F7A4F-E156-4AAC-81BB-D7D062AE1004Q41548341-8A505DAD-23CF-45FC-9EBD-A9BB5C2FAA03Q41590963-92CA561F-BC5D-4863-A69E-64E4E8C3CEDCQ44206359-77E7D0C9-4E0C-4395-BDC8-36E2DF085326Q45108856-7AA09A5B-60B6-4127-8113-1F964CCA5126Q46705569-3BDB5F54-79FD-454B-A935-C4F85EE83273Q47159332-47D84332-BD6C-425E-A2C6-FBC260A515D8Q47306169-47A34FBC-0475-4113-AC3F-A7C1132D3418Q49358066-81EFCD89-8218-4AD3-9EA1-9CD03DC1EA6EQ50065383-E5FD4482-23A4-4601-B376-4C91BE9981E4Q58572438-75D70ABA-5BF0-40A6-ADBB-918F3E3FD1F4Q59277466-B5582429-C756-4ADA-8104-E2E4D8B6B6DE
P2860
Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Risk of subsequent ischemic an ...... de follow-up study from Sweden
@ast
Risk of subsequent ischemic an ...... de follow-up study from Sweden
@en
Risk of subsequent ischemic an ...... de follow-up study from Sweden
@nl
type
label
Risk of subsequent ischemic an ...... de follow-up study from Sweden
@ast
Risk of subsequent ischemic an ...... de follow-up study from Sweden
@en
Risk of subsequent ischemic an ...... de follow-up study from Sweden
@nl
prefLabel
Risk of subsequent ischemic an ...... de follow-up study from Sweden
@ast
Risk of subsequent ischemic an ...... de follow-up study from Sweden
@en
Risk of subsequent ischemic an ...... de follow-up study from Sweden
@nl
P2860
P50
P356
P1433
P1476
Risk of subsequent ischemic an ...... de follow-up study from Sweden
@en
P2860
P2888
P356
10.1186/1471-2377-12-41
P577
2012-06-18T00:00:00Z
P5875
P6179
1021692848